GPT and Jaundice: Additionally, OptAB warns against administrating Ceftriaxone to patients with elevated alanine transaminase values exceeding 280 U/L indicating toxic liver injuries and liver cell damages or increased bilirubin total values higher than 2.4 mg/dl for men and 2.2 mg/dl for woman indicating jaundice and bile duct inflammation (see Methods for detailed information).